Evidence map›Paper›PMID 34471290›Full record

ArticleNature2021

The polar oxy-metabolome reveals the 4-hydroxymandelate CoQ10 synthesis pathway.

Robert S Banh, Esther S Kim, Quentin Spillier, Douglas E Biancur, Keisuke Yamamoto, Albert S W Sohn, Guangbin Shi, Drew R Jones, Alec C Kimmelman, Michael E Pacold

Registry-linked trialAbstract read
In one paragraph

Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05848271 (A Patient Registry and Natural History Study of Patients with Biallelic HPDL Mutations), which is not on this map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05848271 recruitingnot on this mapstarted 2023, after this paper: background citation

A Patient Registry and Natural History Study of Patients with Biallelic HPDL Mutations

TypeobservationalSponsorUniversity of California, San DiegoRan2023 to 2027Enrolled50ConditionsMitochondrial Encephalomyopathies, Hereditary Spastic Paraplegia, Spastic Paraplegia, White Matter DiseaseArmsPatient Registry, Dry blood spots sampling
3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. CoQExperimental & molecular medicine · 2026
    Review
  2. Bypass Treatments for Primary Coenzyme Q10 Deficiency: An Update.International journal of molecular sciences · 2026
    Review
  3. Article
  4. A bioinorganic view on the potential chemical space of hydroxyphenylpyruvate dioxygenase-like (HPDL) enzymes.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. HPDL Variant Type Correlates With Clinical Disease Onset and Severity.Annals of clinical and translational neurology · 2025
    Observational
  15. Review
  16. Article
  17. Quantitative natural history modeling of HPDL-related disease based on cross-sectional data reveals genotype-phenotype correlations.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Robert S BanhDepartment of Radiation Oncology, New York University Langone Health, New York, NY, USA.
Esther S KimDepartment of Radiation Oncology, New York University Langone Health, New York, NY, USA.
Quentin SpillierDepartment of Radiation Oncology, New York University Langone Health, New York, NY, USA.
Douglas E BiancurDepartment of Radiation Oncology, New York University Langone Health, New York, NY, USA.
Keisuke YamamotoDepartment of Radiation Oncology, New York University Langone Health, New York, NY, USA.ORCID http://orcid.org/0000-0002-6323-9540
Albert S W SohnDepartment of Radiation Oncology, New York University Langone Health, New York, NY, USA.
Guangbin ShiDepartment of Radiation Oncology, New York University Langone Health, New York, NY, USA.
Drew R JonesMetabolomics Core Resource Laboratory, New York University Langone Health, New York, NY, USA.
Alec C KimmelmanDepartment of Radiation Oncology, New York University Langone Health, New York, NY, USA.
Michael E PacoldDepartment of Radiation Oncology, New York University Langone Health, New York, NY, USA. michael.pacold@nyulangone.org.ORCID http://orcid.org/0000-0003-3688-2378

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
The RAS and P13K Pathways in Pancreatic AdenocarcinomaP01CA117969 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DEPINHO, RONALD ANTHONY · 2006 to 2025
$41.7M
TRAINING PROGRAM IN MOLECULAR ONCOLOGY &IMMUNOLOGYT32CA009161 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARROLL, WILLIAM L., LEVY, DAVID E · 1985 to 2020
$13.3M
Identifying Metabolic Dependencies of Pancreatic CancersR35CA232124 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KIMMELMAN, ALEC · 2018 to 2024
$6.5M
Network organization of the human autophagy systemR01GM095567 · NIGMS · HARVARD MEDICAL SCHOOL · PI HARPER, JEFFREY W, KIMMELMAN, ALEC · 2011 to 2018
$3.0M
Investigating the Role of Autophagy in Pancreatic Cancer Radiation ResistanceR01CA157490 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KIMMELMAN, ALEC · 2011 to 2018
$2.5M
Role of nonsense mediated RNA decay in pancreatic cancerR01CA211687 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 2018 to 2022
$2.1M
Investigating a Novel Glutamine Metabolism Pathway in Pancreatic CancerR01CA188048 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KIMMELMAN, ALEC · 2015 to 2018
$1.5M
Small molecule approaches to studying tumor metabolismK22CA212059 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PACOLD, MICHAEL EDWARD · 2017 to 2019
$454k
Identifying Metabolic Vulnerabilities in Pancreatic CancerF99CA245822 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BIANCUR, DOUGLAS · 2019 to 2020
$92k
NCI NIH HHS F99 CA245822NCI NIH HHS K22 CA212059NCI NIH HHS P01 CA117969NCI NIH HHS P30 CA016087NCI NIH HHS R01 CA157490NCI NIH HHS R01 CA188048NCI NIH HHS R01 CA211687NCI NIH HHS R35 CA232124NCI NIH HHS T32 CA009161NIGMS NIH HHS R01 GM095567
6 · The paper itself

Abstract

Oxygen is critical for a multitude of metabolic processes that are essential for human life. Biological processes can be identified by treating cells with

Indexed as

Metabolome4-Hydroxyphenylpyruvate DioxygenaseAnimalsCell LineFemaleHumansMandelic AcidsMiceMice, NudeTyrosineUbiquinone4-hydroxymandelic acid4-Hydroxyphenylpyruvate Dioxygenasecoenzyme Q10Mandelic AcidsTyrosineUbiquinone

Identifiers

PMID34471290
PMCPMC8538427

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.